NASDAQ:CEMI

Chembio Diagnostics News Headlines

$2.97
-0.09 (-2.94 %)
(As of 07/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.93
$3.47
50-Day Range
$2.06
$5.34
52-Week Range
$2.06
$8.75
Volume12.37 million shs
Average Volume6.86 million shs
Market Capitalization$60.13 million
P/E RatioN/A
Dividend YieldN/A
Beta1.85

Chembio Diagnostics (NASDAQ CEMI) News Headlines Today

SourceHeadline
Chembio Jumps on OrderChembio Jumps on Order
baystreet.ca - July 26 at 2:07 PM
FY2021 EPS Estimates for Chembio Diagnostics, Inc. (NASDAQ:CEMI) Raised by AnalystFY2021 EPS Estimates for Chembio Diagnostics, Inc. (NASDAQ:CEMI) Raised by Analyst
americanbankingnews.com - July 26 at 2:52 AM
Thinking about buying stock in TAL Education, Chembio Diagnostics, AzurRx BioPharma, Summit Wireless Technologies, or General Electric?Thinking about buying stock in TAL Education, Chembio Diagnostics, AzurRx BioPharma, Summit Wireless Technologies, or General Electric?
benzinga.com - July 23 at 12:35 PM
Chembio Diagnostics Pops And Drops: A Technical LookChembio Diagnostics Pops And Drops: A Technical Look
msn.com - July 22 at 8:20 PM
Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021
finance.yahoo.com - July 22 at 8:20 PM
Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global FundChembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund
finance.yahoo.com - July 22 at 3:19 PM
Chembio Diagnostics Bags $28.3M Oder for SARS-CoV-2 Antigen Tests from BrazilChembio Diagnostics Bags $28.3M Oder for SARS-CoV-2 Antigen Tests from Brazil
nasdaq.com - July 22 at 9:01 AM
Research Analysts Offer Predictions for Chembio Diagnostics, Inc.s Q2 2021 Earnings (NASDAQ:CEMI)Research Analysts Offer Predictions for Chembio Diagnostics, Inc.'s Q2 2021 Earnings (NASDAQ:CEMI)
americanbankingnews.com - July 22 at 8:20 AM
Why Is Chembio Diagnostics (NASDAQ: CEMI) The Best Stock Of The Day?Why Is Chembio Diagnostics (NASDAQ: CEMI) The Best Stock Of The Day?
finance.yahoo.com - July 21 at 6:51 PM
Chembio Diagnostics (NASDAQ:CEMI) Downgraded by Colliers Securities to "Neutral"Chembio Diagnostics (NASDAQ:CEMI) Downgraded by Colliers Securities to "Neutral"
americanbankingnews.com - July 21 at 5:21 PM
Chembio Diagnostics Shares Triple After $28.3M Purchase OrderChembio Diagnostics Shares Triple After $28.3M Purchase Order
marketwatch.com - July 21 at 1:51 PM
Mid-Day Market Update: Crude Oil Up 4%; Chembio Diagnostics Shares Spike HigherMid-Day Market Update: Crude Oil Up 4%; Chembio Diagnostics Shares Spike Higher
markets.businessinsider.com - July 21 at 1:51 PM
Why Chembio Diagnostics Shares Are Trading Higher TodayWhy Chembio Diagnostics Shares Are Trading Higher Today
msn.com - July 21 at 1:51 PM
Day traders are cheering on a small medical-diagnostics company thats soared 237% today after announcing a $28 million orderDay traders are cheering on a small medical-diagnostics company that's soared 237% today after announcing a $28 million order
markets.businessinsider.com - July 21 at 1:51 PM
Chembio Shares Double on $28 Million COVID Diagnostic Test OrderChembio Shares Double on $28 Million COVID Diagnostic Test Order
finance.yahoo.com - July 21 at 1:51 PM
Chembios stock more than doubles off 11-year low after large order for COVID-19 antigen testsChembio's stock more than doubles off 11-year low after large order for COVID-19 antigen tests
finance.yahoo.com - July 21 at 1:51 PM
Traders Purchase High Volume of Call Options on Chembio Diagnostics (NASDAQ:CEMI)Traders Purchase High Volume of Call Options on Chembio Diagnostics (NASDAQ:CEMI)
americanbankingnews.com - July 21 at 11:04 AM
Chembio Stock More Than Doubles On $28M Purchase Order For Its COVID Antigen TestsChembio Stock More Than Doubles On $28M Purchase Order For Its COVID Antigen Tests
msn.com - July 21 at 8:50 AM
Premarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & JohnsonPremarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson
finance.yahoo.com - July 21 at 8:50 AM
Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in BrazilChembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Antigen Tests in Brazil
benzinga.com - July 21 at 3:50 AM
Chembio Diagnostics, Inc. (NASDAQ:CEMI) Short Interest UpdateChembio Diagnostics, Inc. (NASDAQ:CEMI) Short Interest Update
americanbankingnews.com - July 20 at 10:01 AM
Zacks: Analysts Anticipate Chembio Diagnostics, Inc. (NASDAQ:CEMI) to Announce -$0.28 EPSZacks: Analysts Anticipate Chembio Diagnostics, Inc. (NASDAQ:CEMI) to Announce -$0.28 EPS
americanbankingnews.com - July 16 at 3:16 AM
Short Interest in Chembio Diagnostics, Inc. (NASDAQ:CEMI) Declines By 16.8%Short Interest in Chembio Diagnostics, Inc. (NASDAQ:CEMI) Declines By 16.8%
americanbankingnews.com - July 7 at 2:56 AM
Chembio Diagnostics, Inc. (NASDAQ:CEMI) Sees Large Decline in Short InterestChembio Diagnostics, Inc. (NASDAQ:CEMI) Sees Large Decline in Short Interest
americanbankingnews.com - July 5 at 4:28 AM
Chembio Diagnostics (NASDAQ:CEMI) Is Making Moderate Use Of DebtChembio Diagnostics (NASDAQ:CEMI) Is Making Moderate Use Of Debt
nasdaq.com - June 11 at 2:38 PM
The US CDC Isnt Even Sure How Long Vaccines Will Protect UsThe US CDC Isn't Even Sure How Long Vaccines Will Protect Us
benzinga.com - May 31 at 7:45 PM
The US CDC Isn’t Even Sure How Long Vaccines Will Protect UsThe US CDC Isn’t Even Sure How Long Vaccines Will Protect Us
baystreet.ca - May 31 at 2:44 PM
Chembio Diagnostics Reports First Quarter 2021 Financial ResultsChembio Diagnostics Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 6 at 6:45 PM
Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021
finance.yahoo.com - April 22 at 12:00 PM
Chembio Diagnostics Stock Is Believed To Be Modestly UndervaluedChembio Diagnostics Stock Is Believed To Be Modestly Undervalued
ca.finance.yahoo.com - April 15 at 2:34 PM
If You Had Bought Chembio Diagnostics (NASDAQ:CEMI) Shares Three Years Ago You Would Be Down 39%If You Had Bought Chembio Diagnostics' (NASDAQ:CEMI) Shares Three Years Ago You Would Be Down 39%
finance.yahoo.com - April 7 at 8:35 AM
Chembio Jumps on Launch of Test Distinguishing COVID, FluChembio Jumps on Launch of Test Distinguishing COVID, Flu
finance.yahoo.com - April 5 at 6:38 PM
Chembio Diagnostics stock rockets on record volume after commercial launch of rapid COVID-19 testChembio Diagnostics stock rockets on record volume after commercial launch of rapid COVID-19 test
finance.yahoo.com - April 5 at 6:38 PM
Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and FluChembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu
finance.yahoo.com - April 1 at 7:12 PM
Earnings Update: Heres Why Analysts Just Lifted Their Chembio Diagnostics, Inc. (NASDAQ:CEMI) Price Target To US$9.00Earnings Update: Here's Why Analysts Just Lifted Their Chembio Diagnostics, Inc. (NASDAQ:CEMI) Price Target To US$9.00
nasdaq.com - March 13 at 9:26 AM
Chembio Diagnosticss Earnings OutlookChembio Diagnostics's Earnings Outlook
benzinga.com - March 10 at 12:53 PM
Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of DirectorsChembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors
finance.yahoo.com - March 8 at 8:42 AM
Chembio Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021Chembio Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021
finance.yahoo.com - February 25 at 4:51 PM
Do Insiders Own Lots Of Shares In Chembio Diagnostics, Inc. (NASDAQ:CEMI)?Do Insiders Own Lots Of Shares In Chembio Diagnostics, Inc. (NASDAQ:CEMI)?
finance.yahoo.com - February 3 at 7:11 AM
CEMI Jan 2021 5.000 callCEMI Jan 2021 5.000 call
in.finance.yahoo.com - January 16 at 2:48 AM
CEMI Jan 2021 12.500 putCEMI Jan 2021 12.500 put
in.finance.yahoo.com - January 16 at 2:48 AM
Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test SystemsChembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems
finance.yahoo.com - January 14 at 5:45 PM
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of DirectorsChembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors
finance.yahoo.com - December 17 at 7:34 PM
Roche CEO Says Testing Demand Could Outstrip Supply for MonthsRoche CEO Says Testing Demand Could Outstrip Supply for Months
baystreet.ca - December 17 at 9:33 AM
Is Chembio Diagnostics (NASDAQ:CEMI) Using Too Much Debt?Is Chembio Diagnostics (NASDAQ:CEMI) Using Too Much Debt?
finance.yahoo.com - December 5 at 6:24 PM
Stock Alert: Chembio Diagnostics Declines Following FDA ResponseStock Alert: Chembio Diagnostics Declines Following FDA Response
nasdaq.com - December 4 at 4:36 PM
Chembio Diagnostics (CEMI) Surges: Stock Moves 8.5% HigherChembio Diagnostics (CEMI) Surges: Stock Moves 8.5% Higher
finance.yahoo.com - December 3 at 9:25 AM
Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test SystemChembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test System
finance.yahoo.com - December 2 at 6:12 PM
Is Chembio Diagnostics Inc (CEMI) A Good Stock To Buy?Is Chembio Diagnostics Inc (CEMI) A Good Stock To Buy?
finance.yahoo.com - November 27 at 5:34 PM
Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in BrazilChembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in Brazil
finance.yahoo.com - November 13 at 8:11 PM
This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.